Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph J Locascio

Showing results (81-90 of 149) with videos related to

Pageof 15
Sort By:
Biochemical and Biophysical Research Communications|August 26, 2006
Decreased alpha-synuclein in cerebrospinal fluid of aged individuals and subjects with Parkinson's diseaseTakahiko Tokuda, Sultan A Salem, David Allsop, et al.
JAMA Neurology|September 23, 2016
Tau Positron Emission Tomographic Imaging in the Lewy Body DiseasesStephen N Gomperts, Joseph J Locascio, Sara J Makaretz, et al.
International Psychogeriatrics|January 18, 2021
Predictors of the importance of everyday preferences for older adults with cognitive impairmentJames M Wilkins, Joseph J Locascio, Jeanette M Gunther, et al.
Pain Reports|June 9, 2021
Dissociative and analgesic properties of ketamine are independent and unaltered by sevoflurane general anesthesiaEunice Y Hahm, Shubham Chamadia, Joseph J Locascio, et al.
BMC Public Health|April 17, 2015
Adolescents' use of the built environment for physical activityNicolas M Oreskovic, James M Perrin, Alyssa I Robinson, et al.
Anesthesiology|September 8, 2020
Dissociative and Analgesic Properties of Ketamine Are IndependentJacob Gitlin, Shubham Chamadia, Joseph J Locascio, et al.
Journal of Alzheimer'S Disease : JAD|June 6, 2014
Regional fluorodeoxyglucose metabolism and instrumental activities of daily living across the Alzheimer's disease spectrumKamolika Roy, Lesley C Pepin, Marlie Philiossaint, et al.
Alzheimer Disease and Associated Disorders|May 18, 2010
Effects of simvastatin on cholesterol metabolism and Alzheimer disease biomarkersAlberto Serrano-Pozo, Gloria L Vega, Dieter Lütjohann, et al.
Neuro-Degenerative Diseases|July 12, 2007
Serum heart-type fatty acid-binding protein and cerebrospinal fluid tau: marker candidates for dementia with Lewy bodiesBrit Mollenhauer, Petra Steinacker, Erik Bahn, et al.
Journal of Neuropathology and Experimental Neurology|November 20, 2008
Preservation of neuronal number despite age-related cortical brain atrophy in elderly subjects without Alzheimer diseaseStefanie H Freeman, Ruth Kandel, Luis Cruz, et al.
Pageof 15

Showing results (81-90 of 149) with videos related to

Sort By:
Pageof 15
Biochemical and Biophysical Research Communications|August 26, 2006
Decreased alpha-synuclein in cerebrospinal fluid of aged individuals and subjects with Parkinson's diseaseTakahiko Tokuda, Sultan A Salem, David Allsop, et al.
JAMA Neurology|September 23, 2016
Tau Positron Emission Tomographic Imaging in the Lewy Body DiseasesStephen N Gomperts, Joseph J Locascio, Sara J Makaretz, et al.
International Psychogeriatrics|January 18, 2021
Predictors of the importance of everyday preferences for older adults with cognitive impairmentJames M Wilkins, Joseph J Locascio, Jeanette M Gunther, et al.
Pain Reports|June 9, 2021
Dissociative and analgesic properties of ketamine are independent and unaltered by sevoflurane general anesthesiaEunice Y Hahm, Shubham Chamadia, Joseph J Locascio, et al.
BMC Public Health|April 17, 2015
Adolescents' use of the built environment for physical activityNicolas M Oreskovic, James M Perrin, Alyssa I Robinson, et al.
Anesthesiology|September 8, 2020
Dissociative and Analgesic Properties of Ketamine Are IndependentJacob Gitlin, Shubham Chamadia, Joseph J Locascio, et al.
Journal of Alzheimer'S Disease : JAD|June 6, 2014
Regional fluorodeoxyglucose metabolism and instrumental activities of daily living across the Alzheimer's disease spectrumKamolika Roy, Lesley C Pepin, Marlie Philiossaint, et al.
Alzheimer Disease and Associated Disorders|May 18, 2010
Effects of simvastatin on cholesterol metabolism and Alzheimer disease biomarkersAlberto Serrano-Pozo, Gloria L Vega, Dieter Lütjohann, et al.
Neuro-Degenerative Diseases|July 12, 2007
Serum heart-type fatty acid-binding protein and cerebrospinal fluid tau: marker candidates for dementia with Lewy bodiesBrit Mollenhauer, Petra Steinacker, Erik Bahn, et al.
Journal of Neuropathology and Experimental Neurology|November 20, 2008
Preservation of neuronal number despite age-related cortical brain atrophy in elderly subjects without Alzheimer diseaseStefanie H Freeman, Ruth Kandel, Luis Cruz, et al.
Pageof 15